Aura Health Inc. (the “Company” or “Aura”) (CSE: BUZZ) wishes to announce the following changes to its board of directors (the “Board”). Effective immediately, Joel Freudman has been appointed to the Board as an independent director and Chair of the Board’s Audit Committee, subject to regulatory approval by the Canadian Securities Exchange. Mr. Freudman is the President of Resurgent Capital Corp., a Toronto-based merchant bank focused on undervalued micro-cap Canadian public companies. He is also President and CEO and a Director of Trius Investments Inc. (TSXV:TRUH). Mr. Freudman started his career in private practice as a securities and M&A lawyer and subsequently transitioned to in-house legal counsel for various wealth management firms and major Canadian financial institutions. Mr. Freudman is a member of the Law Society of Ontario, holds a Juris Doctor degree from the University of Western Ontario and a Bachelor of Commerce degree from the University of Toronto.

In association with the appointment of Mr. Freudman, Jimmy Gravel has resigned from the Board in order to pursue other business opportunities, effective immediately. The Board would like to thank Mr. Gravel for his service to the Company and wishes him the best in his future endeavours.

Daniel Cohen, CEO of Aura, commented: “We are happy to add Joel to the Board for his corporate governance and transactional expertise, which will help as we accelerate our international growth strategy. At the same time, we also want to sincerely thank Jimmy Gravel for his contributions to the Company and wish him the best in his future endeavours.”

About Aura Health Inc.
Aura, through its wholly-owned Delaware subsidiary Green Global Properties Inc. (“Green Global”), owns a 30% interest in four medical marijuana clinics in Las Vegas, Nevada; Mesa, Arizona; Tucson, Arizona; and Hollywood, Florida. Green Global has an option to increase its interest in each such clinic (other than the Nevada clinic) to 51%.

Aura’s common shares trade on the Canadian Securities Exchange under the symbol “BUZZ”. For updates on the Company’s activities and to see its investor presentation, please visit Aura’s web site at

For further information, please contact:

Daniel Cohen, CEO – (647) 202-1824

David Posner, Director and Chairman – (647) 985-6727

Caution Regarding Forward-Looking Information:

This news release contains “forward-looking information” within the meaning of Canadian securities laws. Generally, forward-looking information can be identified by words and phrases such as “plans”, “expects” “scheduled”, “estimates”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases indicating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken or occur. Forward-looking information in this news release includes, without limitation, statements regarding the Company’s future expansion plans. This forward-looking information consists of disclosure regarding possible events, conditions or results, and is based on numerous assumptions, including that the new director appointment will be approved and that Aura will be able to successfully develop and execute its plans for international growth.

The forward-looking information in this news release is subject to numerous risks and uncertainties that may cause Aura’s actual results or performance to differ materially from those expressed or implied by such forward-looking information, including but not limited to: regulatory approval processes; challenges in business performance and execution; and other risks described in the Company’s continuous disclosure documents. Accordingly, investors should not place undue reliance on such forward-looking information. The Company does not undertake to update any forward-looking information herein, except as may be required by applicable securities laws.


An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less